A Randomized, Open Label, Dose Titration Study to Evaluate the Efficacy and Safety of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia.

Trial Profile

A Randomized, Open Label, Dose Titration Study to Evaluate the Efficacy and Safety of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Mar 2012

At a glance

  • Drugs Atorvastatin; Pitavastatin
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms ESPRIT
  • Sponsors JW Pharmaceutical
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 29 Mar 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top